TNF blockers use during pregnancy not associated with worse fetal or obstetric outcomes Dr. Kamal Kant Kohli12 Nov 2023 8:00 PM ISTAccording to new research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, continuing tumor necrosis factor...
Vedolizumab associated with Higher Risk of Treatment Failure in Older IBD Patients: JAMA Dr. Shravani Dali5 Oct 2022 8:00 PM ISTVedolizumab in older IBD patients is tied with a higher risk for treatment failure according to a recent study published in the JAMA Network Open. ...
TNF inhibitors less effective for patients who developed IBD later in life Medical Dialogues Editorial Team4 April 2022 9:00 AM ISTIn a new retrospective study conducted in Japan by Takahiro Amano and team, it was found that treatment with Tumor necrosis factor (TNF)...
Seropositive RA patients more often adhere to abatacept compared to TNF, JAK Inhibitors: Study Dr. Shravani Dali25 Dec 2021 9:00 AM ISTAmong seropositive RA patients, those on abatacept were more often persistent to their index treatment and had longer time to treatment...
What was the optimal dose of pirfenidone in large studies on idiopathic pulmonary fibrosis? Dr. Kamal Kant Kohli9 Dec 2021 12:00 PM ISTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal lung disease that is characterized by the irreversible loss of lung function....
Improving Clinical Outcomes with the Use of Doxycycline in Dengue and Malaria - An Indian Experience Dr. Syed Bahavudeen Hussaini5 July 2021 12:45 PM ISTDengue and Malaria are major public health diseases in India. In the setting of an ongoing pandemic concurring with monsoons in many parts of the...
